New LaunchMay 18, 2026, 11:02 AM
Philips unveils SmartIQ, IntraSight Plus, DeviceGuide at EuroPCR 2026
AI Summary
Royal Philips is showcasing new innovations at EuroPCR 2026 aimed at enhancing cardiac procedures by integrating imaging, physiology, and AI-enabled guidance. Key introductions include SmartIQ Technology, which reduces X-ray radiation dose by over 50%, IntraSight Plus for comprehensive diagnostic and treatment planning, and DeviceGuide, an AI-enabled solution for real-time device visualization. These advancements focus on improving efficiency, reducing radiation exposure for patients and staff, and supporting procedural confidence in complex interventions.
Key Highlights
- Philips launched SmartIQ Technology, reducing X-ray radiation dose by over 50% compared to current low-dose settings.
- Introduced IntraSight Plus, an intuitive platform for comprehensive diagnostic and treatment planning.
- Unveiled DeviceGuide, an AI-enabled solution for real-time visualization of interventional devices.
- Showcased VeriSight Pro 3D ICE, enabling real-time imaging from inside the heart for structural heart interventions.
- Presented Hemo R2, a unified user interface for hemodynamic functionalities and hospital IT connectivity.
- Innovations aim to improve efficiency and reduce radiation exposure in complex cardiac procedures.
- Philips will host scientific sessions and hands-on education at EuroPCR 2026.
Price Impact
More from PHG